Ozempic and GLP-1 Drugs Linked to Insurance Hikes, Pancreatitis Risk
Ozempic and GLP-1 inhibitors are causing skyrocketing rates of health insurance premiums as serious side effects from the drug have sparked a new UK investigation. GLP-1 inhibitors, including Ozempic and Wegovy, are used for weight loss and to treat diabetes,, but can cost between $1,000 and $1,500 per month for a prescription without insurance. The…Continue reading Ozempic and GLP-1 Drugs Linked to Insurance Hikes, Pancreatitis Risk